Nancy Whiting Acquires 32,000 BOLD Shares

Nancy Whiting made a move by purchasing 32,000 shares of BOLD on June 15, 2026. The transaction did not specify a price, but it's a noteworthy addition to her portfolio.

Insider Buying and Selling at Boundless Bio, Inc.

On June 15, 2026, several insiders, including Nancy Whiting, bought shares of BOLD. Whiting acquired 32,000 shares, while other insiders like James Christensen and Jennifer Lew matched this purchase. Jonathan Lim bought 48,000 shares. Earlier in the year, on January 23, Zachary Hornby, President & CEO, added 600,000 shares, and David Hinkle, Senior VP of Finance, bought 140,000 shares.

Other Institutional Activity in BOLD

Institutional players have been active in BOLD as well. FMR LLC increased its holdings by 11,433 shares, bringing its total to 2,695,455 shares valued at about $2.97 million. Citadel Advisors LLC, however, trimmed its position by 11,773 shares, leaving it with 1,342,131 shares worth approximately $1.48 million. Stonepine Capital Management, LLC significantly reduced its stake by 112,389 shares, now holding 597,682 shares valued at $657,450. Meanwhile, Vanguard Capital Management LLC initiated a new position with 597,192 shares worth $656,911.

BOLD Stock Snapshot

Shares of BOLD recently traded around $1.41. The stock has seen varied activity with a 52-week range stretching from a low to a high that's not specified in the data provided. Investors watch these movements closely, especially given the recent insider and institutional activities.

Analysts Set New Price Targets

Analysts have kept a keen eye on BOLD. On August 11, 2025, HC Wainwright & Co. maintained a 'buy' rating with a $4 price target. Earlier, on June 2, 2025, the firm initiated coverage with a 'buy' rating and a $5 target. Leerink Partners downgraded the stock to 'hold' with a $3 target on May 28, 2025, after initially setting a 'buy' rating at a much higher $25 target in April 2024.

Bottom Line

Nancy Whiting's recent purchase of BOLD shares is part of a broader pattern of insider buying, suggesting confidence in the company's prospects. Institutional adjustments highlight diverse strategies among major players. Investors will continue to monitor these developments, especially with analysts maintaining optimistic ratings. Remember, such insider and institutional activities are backward-looking and may not reflect current positions.